Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque.
作者信息
Egusa Genshi
机构信息
Genshi Egusa Clinic.
出版信息
J Atheroscler Thromb. 2021 Oct 1;28(10):1020-1022. doi: 10.5551/jat.ED156. Epub 2021 Jan 15.
Abstract
摘要
相似文献
1
Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque.
J Atheroscler Thromb. 2021 Oct 1;28(10):1020-1022. doi: 10.5551/jat.ED156. Epub 2021 Jan 15.
2
Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1213-1221. doi: 10.1161/ATVBAHA.117.309101. Epub 2017 May 4.
3
Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease.
Hum Antibodies. 2009;18(3):109-17. doi: 10.3233/HAB-2009-0202.
4
Anti-Lipoprotein Lipase Antibody as a Useful Marker for Plaque Vulnerability in Patients with Stable Angina.
J Atheroscler Thromb. 2024 Jul 1;31(7):1087-1097. doi: 10.5551/jat.64528. Epub 2024 Feb 6.
5
Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
Stroke. 2016 Apr;47(4):1140-3. doi: 10.1161/STROKEAHA.116.012677. Epub 2016 Mar 10.
6
Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
J Pharm Pharmacol. 2002 Dec;54(12):1651-7. doi: 10.1211/002235702306.
7
Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque.
J Atheroscler Thromb. 2021 Oct 1;28(10):1025-1034. doi: 10.5551/jat.58784. Epub 2020 Nov 15.
8
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
Eur Heart J. 2008 Sep;29(18):2218-26. doi: 10.1093/eurheartj/ehn336. Epub 2008 Jul 29.
9
The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Biochem Biophys Res Commun. 2015 Aug 14;464(1):306-11. doi: 10.1016/j.bbrc.2015.06.148. Epub 2015 Jun 24.
10
[Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis].
Ter Arkh. 2016;88(9):31-38. doi: 10.17116/terarkh201688931-38.
引用本文的文献
1
ApoB100 and Atherosclerosis: What's New in the 21st Century?
Metabolites. 2024 Feb 12;14(2):123. doi: 10.3390/metabo14020123.
本文引用的文献
1
Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque.
J Atheroscler Thromb. 2021 Oct 1;28(10):1025-1034. doi: 10.5551/jat.58784. Epub 2020 Nov 15.
2
Apolipoprotein B-100 peptide 210 antibody inhibits atherosclerosis by regulation of macrophages that phagocytize oxidized lipid.
Am J Transl Res. 2018 Jun 15;10(6):1817-1828. eCollection 2018.
3
The immunology of atherosclerosis.
Nat Rev Nephrol. 2017 Jun;13(6):368-380. doi: 10.1038/nrneph.2017.51. Epub 2017 Apr 10.
4
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
Eur Heart J. 2008 Sep;29(18):2218-26. doi: 10.1093/eurheartj/ehn336. Epub 2008 Jul 29.
5
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease.
Stroke. 2007 May;38(5):1495-500. doi: 10.1161/STROKEAHA.106.474577. Epub 2007 Mar 15.
6
Pathology of the vulnerable plaque.
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8. doi: 10.1016/j.jacc.2005.10.065.
7
Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
Atherosclerosis. 2006 Sep;188(1):160-6. doi: 10.1016/j.atherosclerosis.2005.10.017. Epub 2005 Nov 22.
8
Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population.
J Lipid Res. 2005 Mar;46(3):452-7. doi: 10.1194/jlr.M400290-JLR200. Epub 2004 Dec 16.
9
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):879-84. doi: 10.1161/01.ATV.0000067937.93716.DB. Epub 2003 Mar 20.
10
Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):872-8. doi: 10.1161/01.ATV.0000067935.02679.B0. Epub 2003 Mar 20.
Zotero 插件